Friday, June 29, 2018

Strong Stomach Needed to Fly Brazilian Skies With Airline Stocks Battered

LISTEN TO ARTICLE 3:05 SHARE THIS ARTICLE Facebook Twitter LinkedIn Email

Fuel prices are up, the U.S. dollar is rallying and that means stormy skies for Brazilian airlines.

Gol Linhas Aereas Inteligentes SA is leading Brazil’s Ibovespa index losses month-to-date, with a 21 percent drop so far. The company is also heading for its biggest quarterly drop since its initial public offering in 2004. Gol and Azul SA are down 51 percent and 44 percent, respectively, in the past three months and LATAM Airlines Group SA fell 29 percent.

Oil prices are up 14 percent in New York for the period -- the fourth consecutive quarterly advance -- and the Bloomberg Dollar Spot surged 6 percent as risks to global oil supply pile up. At the same time, the real lost 14 percent of its value against the dollar. The combination is damaging for the local carriers, which get the bulk of their revenue in local currency while more than half of their expenses, including fuel and aircraft maintenance, are linked to the dollar.

#lazy-img-328963969:before{padding-top:56.25%;}

On June 25, Morgan Stanley slashed the price target of Gol American depositary receipts to $7 from $15, noting the high sensitivity of company’s earnings and net income to currency and jet fuel movements.

"We stay equalweight given today’s elevated political uncertainty, the high beta nature of the stock and a potential scenario of further real weakening," analysts led by Josh Milberg wrote in the report.

About 85 percent of Gol’s gross debt was U.S.-denominated by the end of the first quarter, and revenue is almost entirely in reais. The weaker real, combined with a limited hedging policy, leaves it more exposed to foreign exchange fluctuations than its rivals, said Citigroup Inc. analyst Stephen Trent in a phone interview.

“From an operational perspective, the differences are not as significant but from a balance sheet perspective the differences can be significant,” Trent, who has a neutral rating on the stock, said. “How they funded the right side of the balance sheet might now be having an impact.”

Sao Paulo-based Gol declined to comment on its foreign-exchange exposure and its hedging policy for this story.

#lazy-img-328946191:before{padding-top:56.25%;}

Azul, Brazil’s third-largest airline, had 35 percent of its total debt denominated in U.S. dollars by the end of the first quarter, according to its quarterly statement. Its hedging policy is also designed to shield the company from the foreign exchange swings, Chief Executive Officer John Rodgerson said in an interview.

“We have a lot less exposure to the dollar than any of our competitors do,” Rodgerson said in a June 6 interview. “We made the decision to hedge all of our unsecured debt; our competitors haven’t done that. We still have aircraft financed in local currency, the Embraers, and we’ve got U.S. dollar-denominated assets, like our ownership in TAP in Portugal.”

Azul’s lower exposure to foreign exchange risk hasn’t, however, prevented its shares from dropping 20 percent this month, the second-worst performance in the IBX index, behind Gol. Santiago-based Latam Airlines Group SA, the second-largest player in Brazil, fell 13 percent in the month, the second-worst performance in the IPSA Chilean benchmark index.

Latam didn’t immediately return a request for comment.

— With assistance by Ricardo Strulovici Wolfrid, and Aline Oyamada

Monday, June 25, 2018

Why AMD Isn't Gaining Traction in Notebooks

My colleague Tim Green recently commented on a research note that came out, suggesting that�Advanced Micro Devices�(NASDAQ:AMD) hasn't been able to gain market segment share with its new Ryzen Mobile processors for laptops. In fact, the report Green cites claims that AMD is actually still�losing�market segment share in the laptop processor market despite having rolled out new products that appear to be more competitive than the company's prior-generation chips were.�

In this column, I'd like to offer my thoughts on just why, despite AMD's progress in gaining share in the enthusiast desktop processor market, the company's new Ryzen Mobile chips don't seem to be moving the needle.

The AMD Ryzen logo.

Image source: AMD.

Intel's broader portfolio

Chip giant�Intel (NASDAQ:INTC) is the leading vendor of personal computer processors, with overwhelmingly dominant market share in both the desktop and notebook computer markets. However, Intel's dominance is much more pronounced in the notebook computer processor market than it is in the desktop computer processor market.�

There are, in my view, several good reasons for this.

Firstly, Intel's product portfolio in the notebook market is substantially broader than AMD's. Intel's current lineup includes (or will shortly include) the following processor lines, each targeting specific sub-segments of the notebook computer market:�

Gemini Lake for the very low-cost and low-power notebook processor segment. Kaby Lake-Y and, soon, Amber Lake-Y for fan-less notebooks and 2 in 1 notebook/tablet hybrids. Kaby Lake-U and, soon, Whiskey Lake-U for mainstream, low-power notebooks. Coffee Lake-U for premium thin-and-light notebooks. Coffee Lake-H for high-end notebooks, gaming notebooks, and mobile workstations.�

This broad range of processors allows Intel to have really good products for every type of notebook computer a computer maker could conceivably want to build. By contrast, AMD doesn't really have products that can compete against the Gemini Lake parts at the low end, the Y-series parts in very low-power systems, and the Coffee Lake-H parts at the very high end.�

The fact that AMD isn't addressing as wide of a range of computers as Intel probably limits its ability to gain share. However, the story doesn't end there.

Notebook computers are sold as pre-built systems from computer makers, so winning in the notebook computer market means a company has to win at a platform level.�

The reality is that Intel's portfolio of products that it can bring to bear in the notebook computer market is much broader than AMD's. Intel not only builds the processors, it also invests significantly in developing reference designs for the system vendors to build off of. In addition, Intel offers complementary components such as Wi-Fi chips, NAND flash, Optane memory, LTE chips, and is increasingly co-developing things like lower-power displays with major ecosystem partners.

AMD simply can't, at least right now, afford to develop the breadth and depth of platform technologies that Intel can.�

More than just products

Another thing to keep in mind is that neither Intel nor AMD sells notebook processors directly to customers; these processors are sold as parts of finished systems to consumers.�

In addition to Intel's extensive co-engineering efforts with system makers that, frankly, I don't think AMD has the resources to match, there's also the fact that Intel's brand is simply much stronger than AMD's. According to Interbrand, Intel is the 15th most valuable brand in the world, worth nearly $40 billion. By contrast, AMD doesn't even make the list.�

The strength of Intel's brand among consumers makes it more likely that if a consumer has to pick a computer, that consumer will recognize and trust the Intel brand and go with the Intel-powered computer.�

Moreover, Intel's brand strength isn't just a product of Intel's past successes. If you look at how much Intel spends on marketing compared to AMD, they're not even in the same ballpark. In 2017, Intel spent a whopping $7.47 billion on marketing, general, and administrative expenses. AMD, on the other hand, spent just $511 million -- less than 7% of what Intel spent.�

It's just difficult for AMD to fight Intel's sheer brand power and marketing muscle in the personal computer market, and in particular, the notebook computer market.�

Sunday, June 24, 2018

F&O expiry due in this week! Options Pain is an add-on indicator for expiry trading

Shubham Agrawal

Expiry trading is highly attractive to a majority of Options Traders where buyers are hunting for last moment large surges for a high return on investment whereas on the other side Option Writers are busy analysing levels beyond which the index or the stock might not expire to earn small absolute premiums of the OTM options.

But, the base of all is at which point expiry will happen?

Well, there isn��t a way to exactly forecast the level precisely to my knowledge but there are several add-on indicators traders used to gauge the possible level of expiry two of them being recent Value Weighted Average Price (VWAP) of the underlying and Option Pain level derived from Open Interest and Intrinsic value of options for possible expiry levels.

related news Top 6 factors to consider when you pick stocks for intraday trading Thank God! India among top EMs that show no signs of major financial stress Saurabh Mukherjea suggests moving away from midcaps to derisk your portfolio

If a trader is able to successfully forecast the level; or a narrow range of expiry, there exists several strategies which can be of high yield namely: Short Straddle, Short Strangle or a hedged strategy with a high reward to risk ratio along-with limited risk i.e. Butterflies.

Let��s learn both the methods for creating a forecast for expiry.

VWAP:

Value Weighted Average Price of the recent past for the underlying instrument can suggest an average price where buyers and sellers form equilibrium and hence, the level is expected to form an approximation for expiry.

However, there is no thumb rule of what time period should be considered as an input to this calculation. But, a more sensible way out would be to calculate VWAP��s from significant recent swing movements of peaks and troughs.

Option Pain:

Calculation

Option pain is a calculation to find a level at which Option buyers will have a maximum loss and as derivative is a Zero-sum game, it means Options Sellers will make maximum profits or least losses at this point.

The pain level is calculated by multiplying the Open Interest with the intrinsic value of options for different levels of expiries for each strike. The pain line is derived by adding the Call P&L along-with the Put P&L at each strike.

The level which comes as the maximum profit or lowest loss is the level of Option Pain.

Concept:

The reasoning behind tracking the pain level is first, Option writers are expected to be the smart money around as they take the unlimited risk for a very little profit so they tend to have a well-researched approach.

Secondly, option writers adjust positions with their revised forecasts of the market and the market as a whole tends to that equilibrium.

The Flaw:

Option Pain is not a complete calculation as the formula doesn��t account for the premium inflow that the Option writers already received and even though some strikes might show losses where the Option writers may have made significant returns from premium erosion.

Similarly, few strikes may have been under-estimated too. A better approach would be to adjust for the premium received but is certainly a difficult task to perform as trades takes place on a continuous basis and the price is certainly not constant.

High Probability Areas:

Option Pain in our study has been mildly accurate if used raw but a filtration from other technical analysis or derivative analysis tools to decode if the underlying is in a trend or oscillation can help raise the odds of the forecast being right.

Pain level will be respected more in an oscillating market rather than in a market which has a very sharp trend. Lastly, Indices are much more stable for this tool over stocks.

Disclaimer: The author is CEO & Head of Research at Quantsapp Private Limited. The views and investment tips expressed by investment expert on moneycontrol.com are his own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions. First Published on Jun 23, 2018 10:43 am

Wednesday, June 20, 2018

Top 5 Performing Stocks To Own For 2018

tags:HFWA,HOT,UFAB,JAG,PQ,

Source: ThinkstockMay 18, 2018: The S&P 500 closed down 0.3% �at 2,713.01. The DJIA closed flat at 24,716.60. Separately, the Nasdaq was down 0.4% at 7,354.34.

Friday was a mixed day for the broad U.S. markets. While the S&P 500 and the Nasdaq each traded lower over the course of the day, the Dow had a relatively positive day until it sold off at the close. Crude oil backed off to close out the week, but this was only marginal. The S&P 500 sectors were mostly negative. The most positive sectors were industrials and health care, up 0.6% and 0.3%, respectively. The worst performing sectors were financials and energy down 0.8%, and 0.7%, respectively.

Crude oil was down 0.2% at $71.32.

Gold was up 0.3% at $1,292.60.

Top 5 Performing Stocks To Own For 2018: Heritage Financial Corporation(HFWA)

Advisors' Opinion:
  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Heritage Financial (HFWA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    PCSB Bank (NASDAQ: PCSB) and Heritage Financial (NASDAQ:HFWA) are both small-cap finance companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, valuation, risk, earnings and institutional ownership.

Top 5 Performing Stocks To Own For 2018: Starwood Hotels & Resorts Worldwide, Inc.(HOT)

Advisors' Opinion:
  • [By Ethan Ryder]

    Independent Research set a €156.00 ($185.71) price objective on Hochtief (FRA:HOT) in a research note issued to investors on Friday morning. The brokerage currently has a neutral rating on the stock.

  • [By Shane Hupp]

    Hydro Protocol (CURRENCY:HOT) traded up 3.5% against the dollar during the 24-hour period ending at 22:00 PM E.T. on June 14th. During the last seven days, Hydro Protocol has traded down 28.5% against the dollar. One Hydro Protocol token can currently be bought for approximately $0.0392 or 0.00000594 BTC on popular cryptocurrency exchanges including BigONE, DDEX and OKEx. Hydro Protocol has a total market cap of $27.49 million and $967,051.00 worth of Hydro Protocol was traded on exchanges in the last 24 hours.

  • [By Ethan Ryder]

    Holo (CURRENCY:HOT) traded down 9.1% against the US dollar during the 24 hour period ending at 8:00 AM Eastern on June 11th. Holo has a total market cap of $109.14 million and $2.40 million worth of Holo was traded on exchanges in the last day. One Holo token can now be purchased for about $0.0008 or 0.00000012 BTC on popular cryptocurrency exchanges including IDEX, Radar Relay, Hotbit and Fatbtc. During the last seven days, Holo has traded down 17.3% against the US dollar.

Top 5 Performing Stocks To Own For 2018: Unique Fabricating, Inc.(UFAB)

Advisors' Opinion:
  • [By Stephan Byrd]

    Media coverage about Unique Fabricating (NASDAQ:UFAB) has trended somewhat positive this week, Accern Sentiment reports. The research firm scores the sentiment of news coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Unique Fabricating earned a media sentiment score of 0.18 on Accern’s scale. Accern also assigned media stories about the company an impact score of 47.3756147302874 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

  • [By Ethan Ryder]

    Unique Fabricating (NYSEAMERICAN:UFAB)‘s stock had its “buy” rating reaffirmed by equities researchers at Roth Capital in a report released on Wednesday.

Top 5 Performing Stocks To Own For 2018: Jagged Peak Energy Inc. (JAG)

Advisors' Opinion:
  • [By Logan Wallace]

    These are some of the media headlines that may have effected Accern’s scoring:

    Get Jagged Peak Energy alerts: Jagged Peak Energy (JAG) Raised to “Hold” at Zacks Investment Research (americanbankingnews.com) Jagged Peak Energy (JAG) Upgraded to “Hold” by ValuEngine (americanbankingnews.com) Jagged Peak Energy (JAG) Set to Announce Earnings on Thursday (americanbankingnews.com) Insider Selling: Jagged Peak Energy Inc (JAG) CFO Sells 50,000 Shares of Stock (americanbankingnews.com) Jagged Peak Energy Inc (JAG) Given Consensus Recommendation of “Hold” by Analysts (americanbankingnews.com)

    Jagged Peak Energy stock opened at $14.25 on Friday. The company has a current ratio of 0.35, a quick ratio of 0.35 and a debt-to-equity ratio of 0.22. Jagged Peak Energy has a 1-year low of $11.21 and a 1-year high of $16.55. The company has a market capitalization of $2,993.81, a P/E ratio of 54.81 and a beta of -1.13.

  • [By Motley Fool Staff]

    JAGGED PEAK ENERGY INC. (NYSE:JAG) Q1 2018 Earnings Conference CallMay. 11, 2018 11:00 a.m. ET

    Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

    Operator

  • [By Lisa Levin]

     

    Companies Reporting After The Bell NVIDIA Corporation (NASDAQ: NVDA) is estimated to post quarterly earnings at $1.45 per share on revenue of $2.89 billion. News Corporation (NASDAQ: NWSA) is projected to post quarterly earnings at $0.07 per share on revenue of $1.99 billion. Symantec Corporation (NASDAQ: SYMC) is estimated to post quarterly earnings at $0.39 per share on revenue of $1.19 billion. Pilgrim's Pride Corporation (NASDAQ: PPC) is projected to post quarterly earnings at $0.54 per share on revenue of $2.65 billion. Hawaiian Electric Industries, Inc. (NYSE: HE) is expected to post quarterly earnings at $0.38 per share on revenue of $556.81 million. Air Lease Corporation (NYSE: AL) is estimated to post quarterly earnings at $1.01 per share on revenue of $383.37 million. Flowserve Corporation (NYSE: FLS) is expected to post quarterly earnings at $0.27 per share on revenue of $880.89 million. Civitas Solutions, Inc. (NYSE: CIVI) is projected to post quarterly earnings at $0.12 per share on revenue of $396.25 million. The Trade Desk, Inc. (NASDAQ: TTD) is estimated to post quarterly earnings at $0.1 per share on revenue of $73.23 million. Amdocs Limited (NYSE: DOX) is projected to post quarterly earnings at $0.95 per share on revenue of $980.50 million. Yelp Inc. (NYSE: YELP) is estimated to post quarterly loss at $0.04 per share on revenue of $220.14 million. Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC) is expected to post quarterly earnings at $0.43 per share on revenue of $210.01 million. TiVo Corporation (NASDAQ: TIVO) is projected to post quarterly earnings at $0.37 per share on revenue of $198.62 million. Ritchie Bros. Auctioneers Incorporated (NYSE: RBA) is expected to post quarterly earnings at $0.17 per share on revenue of $153.87 million. Uniti Group Inc. (NASDAQ: UNIT) is estimated to post quarterly earnings at $0.01 per share on revenue of $247.16 million. Jagged Peak En

Top 5 Performing Stocks To Own For 2018: Petroquest Energy Inc(PQ)

Advisors' Opinion:
  • [By Ethan Ryder]

    News headlines about Petroquest Energy (NYSE:PQ) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Petroquest Energy earned a coverage optimism score of 0.05 on Accern’s scale. Accern also gave news stories about the energy company an impact score of 47.638327846877 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Tuesday, June 19, 2018

Hot Clean Energy Stocks To Own For 2019

tags:GRMN,EGY,GLMD,

It's important for investors to know how to invest in penny stocks safely. That's because they're often volatile and can sometimes be fraudulent, despite offering triple-digit returns in a matter of weeks. We'll show you our top two strategies for finding good penny stocks to buy, plus our small-cap stock pick primed for double-digit growth this year…

Video3 Strategies for Investing in Penny Stocks

If you're looking for proof of just how explosively profitable penny stocks are, Delcath Systems Inc. (Nasdaq: DCTH) is a perfect piece of evidence. This company saw its stock price surge from $0.02 on June 1 to $0.19 on June 26. That marked a stunning 850% gain, which happened after the company announced phase 2 trial data for its cancer drug Melphalan would be released.

But these triple-digit returns aren't always justified by the company's profits or business potential. For instance, Chinese energy company Hongli Clean Energy Technologies Corp. (Nasdaq: CETC) saw shares jump 144% from $1.90 to $4.63 during just the first five sessions of April.

Hot Clean Energy Stocks To Own For 2019: Garmin Ltd.(GRMN)

Advisors' Opinion:
  • [By Demitrios Kalogeropoulos]

    Garmin (NASDAQ:GRMN) is navigating those challenges better than most industry participants. With help from a wide portfolio that spans fitness wearables, GPS-enabled hiking watches, and products aimed at fishing fans and aviation enthusiasts, the company showed this past week how its business approach can deliver steady revenue and profit growth in a tough selling environment.

  • [By Shane Hupp]

    FLIR Systems (NASDAQ: FLIR) and Garmin (NASDAQ:GRMN) are both aerospace companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and risk.

  • [By Chris Hill]

    Apple (NASDAQ:AAPL)�and Fitbit (NYSE:FIT)�aren't the only players in the smartwatch game. In this episode of MarketFoolery, host Chris Hill and analyst David Kretzmann dive into Garmin (NASDAQ:GRMN), the technology company that you might remember getting completely crushed by GPS-enabled smartphones a few years ago. Things are looking up for Garmin, and long-term investors might want to take a closer look at the company today.

  • [By Paul Ausick]

    Competitors like Fitbit Inc. (NYSE: FIT), Garmin Ltd. (NASDAQ: GRMN) and Alphabet Inc. (NASDAQ: GOOGL), with its Wear OS, are also expected to gain more traction through the forecast period.

Hot Clean Energy Stocks To Own For 2019: Vaalco Energy Inc(EGY)

Advisors' Opinion:
  • [By Lisa Levin] Gainers Cara Therapeutics, Inc. (NASDAQ: CARA) rose 18.2 percent to $13.71 in pre-market trading. Cara Therapeutics and Vifor Fresenius Medical Care Renal Pharma entered into ex-U.S. licensing agreement to commercialize KORSUVA™ injection in dialysis patients with pruritus. Heat Biologics, Inc. (NASDAQ: HTBX) shares rose 10.6 percent to $2.20 in pre-market trading after surging 12.43 percent on Tuesday. VAALCO Energy, Inc. (NYSE: EGY) rose 10.5 percent to $2.37 in pre-market trading after dropping 10.04 percent on Tuesday. Boxlight Corporation (NASDAQ: BOXL) rose 8.3 percent to $7.15 in pre-market trading after falling 16.03 percent on Tuesday. Tiffany & Co. (NYSE: TIF) rose 7.8 percent to $110.25 in pre-market trading after the company reported upbeat results for its first quarter and raised its FY2018 earnings guidance. Heat Biologics, Inc. (NASDAQ: HTBX) shares rose 7.1 percent to $2.13 in pre-market trading. after climbing 12.43 percent on Tuesday. Clementia Pharmaceuticals Inc. (NASDAQ: CMTA) rose 5.9 percent to $20.01 in pre-market trading after reporting positive Phase 2 Part B data showing treatment with palovarotene significantly reduces new bone growth in patients with FOP. Under Armour, Inc. (NYSE: UA) rose 3.5 percent to $18.44 in pre-market trading. Aegean Marine Petroleum Network Inc. (NYSE: ANW) shares rose 3.5 percent to $2.95 in pre-market trading. MetLife, Inc. (NYSE: MET) rose 3.2 percent to $50.00 in pre-market trading after reporting a $1.5 billion buyback plan. Lowe's Companies, Inc. (NYSE: LOW) rose 3.2 percent to $88.51 in pre-market trading. Lowe's reported downbeat results for its first quarter on Wednesday.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Lisa Levin] Gainers Cara Therapeutics, Inc. (NASDAQ: CARA) shares surged 42.76 percent to close at $16.56 on Wednesday in reaction to a new licensing agreement with Europe-based Vifor Pharma. As part of the agreement, the biopharmaceutical company that alleviates pain licensed worldwide rights (except U.S., Japan, and South Korea) to Vifor Pharma to commercialize its KORSUVA therapy to Vifor $70 million. Yangtze River Port and Logistics Limited (NASDAQ: YRIV) gained 31.28 percent to close at $7.05 on Wednesday. Tiffany & Co. (NYSE: TIF) climbed 23.29 percent to close at $126.05 after the company reported upbeat results for its first quarter and raised its FY2018 earnings guidance. EVO Payments, Inc. (NASDAQ: EVOP) gained 18.88 percent to close at $19.02. EVO Payments priced its IPO at $16 per share. Carver Bancorp, Inc. (NASDAQ: CARV) rose 16.1 percent to close at $6.85. USA Technologies, Inc. (NASDAQ: USAT) gained 15.68 percent to close at $13.65 after announcing pricing of public offering. eXp World Holdings, Inc. (NASDAQ: EXPI) shares jumped 15.01 percent to close at $17.70. Geron Corporation (NASDAQ: GERN) gained 14.99 percent to close at $4.68. Evolus, Inc. (NASDAQ: EOLS) rose 14.62 percent to close at $19.36. Ralph Lauren Corporation (NYSE: RL) shares rose 14.34 percent to close at $133.33 after the company reported stronger-than-expected results for its fourth quarter. Turtle Beach Corporation (NASDAQ: HEAR) jumped 13.26 percent to close at $17.34 on Wednesday. Turtle Beach S-3 showed registration for 1.857 million share common stock offering via selling holders. Communications Systems, Inc. (NASDAQ: JCS) rose 13.18 percent to close at $3.95. Communications Systems reported establishment of special committee to explore strategic alternatives. Immutep Limited (NASDAQ: IMMP) shares climbed 12.95 percent to close at $2.53. xG Technology, Inc. (NASDAQ: XGTI) rose 12.64 percent to close at $0.8561 after the company&rsq
  • [By Lisa Levin] Gainers Cara Therapeutics, Inc. (NASDAQ: CARA) shares jumped 28.5 percent to $14.91 in reaction to a new licensing agreement with Europe-based Vifor Pharma. As part of the agreement, the biopharmaceutical company that alleviates pain licensed worldwide rights (except U.S., Japan, and South Korea) to Vifor Pharma to commercialize its KORSUVA therapy to Vifor $70 million. EVO Payments, Inc. (NASDAQ: EVOP) rose 21.5 percent to $19.44. EVO Payments priced its IPO at $16 per share. Tiffany & Co. (NYSE: TIF) jumped 16.3 percent to $118.92 after the company reported upbeat results for its first quarter and raised its FY2018 earnings guidance. Ralph Lauren Corporation (NYSE: RL) shares gained 13.4 percent to $132.225 after the company reported stronger-than-expected results for its fourth quarter. OneSmart International Edun Gr Ltd – ADR (NYSE: ONE) shares rose 12.2 percent to $13.52 Heat Biologics, Inc. (NASDAQ: HTBX) shares gained 11.4 percent to $2.2164 after surging 12.43 percent on Tuesday. USA Technologies, Inc. (NASDAQ: USAT) rose 10.4 percent to $13.02 after announcing pricing of public offering. KemPharm, Inc. (NASDAQ: KMPH) gained 10.3 percent to $6.725. Janney Capital initiated coverage on KemPharm with a Buy rating. Heat Biologics, Inc. (NASDAQ: HTBX) shares rose 10 percent to $2.1894 after climbing 12.43 percent on Tuesday. Lowe's Companies, Inc. (NYSE: LOW) rose 9.5 percent to $93.92. Lowe's reported downbeat results for its first quarter on Wednesday. xG Technology, Inc. (NASDAQ: XGTI) jumped 9.1 percent to $0.829 after the company’s subsidiary IMT Vislink received a $1.4 million order from the U.S. Air Force. VAALCO Energy, Inc. (NYSE: EGY) rose 8.6 percent to $2.34 after dropping 10.04 percent on Tuesday. American Equity Investment Life Holding Company (NYSE: AEL) rose 8.4 percent to $34.99. American Equity Investment Life confirmed preliminary talks related to a potential deal. Boxl

Hot Clean Energy Stocks To Own For 2019: Galmed Pharmaceuticals Ltd.(GLMD)

Advisors' Opinion:
  • [By Shane Hupp]

    Here are some of the media stories that may have effected Accern’s rankings:

    Get Galmed Pharmaceuticals alerts: Galmed Pharmaceuticals’ (GLMD) CEO Allen Baharaff on Q1 2018 Results – Earnings Call Transcript (seekingalpha.com) What You Must Know About Galmed Pharmaceuticals Ltd��s (NASDAQ:GLMD) Market Risks (finance.yahoo.com) Obeticholic Acid Market Analysis, Recent Trends and Regional Growth Forecast by Types, Applications and Economic … (theexpertconsulting.com) oholic Steatohepatitis (NASH) Market 2023: Know Marketing Channel Future Trend, Growth and Price with Future … (theexpertconsulting.com) Umbilical Cord Blood May Offer Early FH Diagnosis (medscape.com)

    A number of equities analysts have recently commented on GLMD shares. ValuEngine lowered shares of Galmed Pharmaceuticals from a “hold” rating to a “sell” rating in a report on Wednesday, February 14th. Maxim Group set a $14.00 price target on shares of Galmed Pharmaceuticals and gave the stock a “buy” rating in a report on Wednesday, May 9th. Finally, HC Wainwright lifted their price target on shares of Galmed Pharmaceuticals from $18.00 to $24.00 and gave the stock a “buy” rating in a report on Monday, February 12th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $20.40.

  • [By George Budwell]

    Over the last two weeks, shares of�Madrigal Pharmaceuticals (NASDAQ:MDGL), Galmed Pharmaceuticals (NASDAQ:GLMD), and Viking Therapeutics (NASDAQ:VKTX) have more than doubled in value. The reason?

  • [By Keith Speights]

    That's exactly what happened this week with three small biotech stocks. Galmed Pharmaceuticals (NASDAQ:GLMD), Galectin Therapeutics (NASDAQ:GALT), and Eloxx Pharmaceuticals (NASDAQ:ELOX) soared on news that excited investors. Here's what drove these stocks higher -- and whether or not they're smart picks for investors now.